Also from this source

You just read:

Resverlogix Establishes Clinical & Scientific Advisory Board to Support the Clinical Development of RVX-208 and Other Bromodomain Inhibitors in Neurodegenerative Diseases

News provided by

Resverlogix Corp.

Jul 16, 2012, 07:30 ET